Crossmark

Molecular mechanisms of phytoconstituents from selected Egyptian plants against non-small cell lung cancer using integrated in vitro network pharmacology and molecular docking approach

Crossref DOI link: https://doi.org/10.1007/s00210-025-03834-4

Published Online: 2025-01-31

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shaala, Lamiaa A.

Youssef, Diaa T. A.

Ramadan, Mahmoud A.

Khalifa, Azza A.

Ibrahim, Reham S.

Valeriote, Fred

Celik, Ismail

Dawood, Hend M.
Funding

Funding for this research was provided by:

Alexandria University
License Information

Text and Data Mining valid from 2025-01-31

Version of Record valid from 2025-01-31
More Information

Article History

Received: 14 December 2024

Accepted: 18 January 2025

First Online: 31 January 2025

Declarations

:

: All methods were performed in accordance with the relevant guidelines and regulations. The use of human cell lines was approved by the Ethical Committee of Alexandria University, Alexandria, Egypt (Approval No: 062023720342A).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below